G-FRAME ZGMF/A-42S2 Destiny Gundam Spec II [Final Battle Image Color], Premium Bandai

Mobile Suit Gundam G Frame FA ZGMF/A-42S2 Destiny Gundam Spec II [Final Battle Image Color] from Mobile Suit Gundam SEED FREEDOM is released as a high-spec movable candy toy figure by Premium Bandai and Bandai's Candy Division.

Premium Bandai Candy Division G Frame FA ZGMF/A-42S2 Destiny Gundam Spec II [Final Battle Image Color] from Mobile Suit Gundam SEED FREEDOM

Bandai is releasing the "Mobile Suit Gundam G Frame FA Destiny Gundam Spec II [Final Battle Image Color]" as a Premium Bandai exclusive candy toy figure!

Based on the Destiny Gundam Spec II from the movie Mobile Suit Gundam SEED FREEDOM, this special G Frame FA release recreates the machine's distinctive final-battle appearance. The updated body colors are faithfully represented, along with the red coloration of the joints seen when the mobile suit's systems were activated during the final battle.

The fully articulated figure comes with a wide range of weapons and effect parts, including the Arondight Beam Sword, High-Energy Long-Range Beam Cannon, beam boomerangs, and beam shield. The set also includes the Experimental 35-Type Modified Railgun, giving the Destiny Gundam Spec II an even wider range of display options.

Palma Fiocina effect parts and large "Wings of Light" effect parts are also included, allowing collectors to recreate the spectacular appearance of the Destiny Gundam Spec II during its intense battle against the Black Knights Squad in Mobile Suit Gundam SEED FREEDOM.

Details

• Mobile Suit Gundam G Frame FA Destiny Gundam Spec II [Final Battle Image Color] [Premium Bandai Exclusive]
• Single item contents:
  • 1 set of pre-painted figure (partial assembly)
  • 1 piece of gum (soda flavor)
• Material: ABS, MABS
• Size: Height approximately 110mm × Width approximately 70mm
• Publisher: Bandai Candy Division
• Price: 6,545 yen (tax included)
• Pre-orders began at 1:00 PM on Friday, August 21, 2026, exclusively on Premium Bandai
• Scheduled for shipment in March 2027